Lasmiditan: New first-in-class drug treatment approved for migraine

The first of a new class of medications for the treatment of migraine has been approved by the FDA. Lasmiditan works differently than existing medications, and does not cause blood vessels to narrow (a side effect that makes them unsuitable for those with vascular conditions).